MediciNova
MNOV
30 hedge funds and large institutions have $11M invested in MediciNova in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 5 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
6% more capital invested
Capital invested by funds: $10.4M → $11M (+$626K)
0.62% more ownership
Funds ownership: 10.05% → 10.67% (+0.62%)
0% more funds holding
Funds holding: 30 → 30 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$379K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$166K |
| 3 |
Citigroup
New York
|
+$105K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$72.1K |
| 5 |
State Street
Boston,
Massachusetts
|
+$34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$162K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$45.1K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$44K |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$39.9K |
| 5 |
Goldman Sachs
New York
|
-$21.5K |
MNOV Hedge Fund Activity: Q4 2024 in Review
30 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q4 2024, worth a combined $11M — up 6% from $10.4M a quarter earlier.
Fund positioning in MNOV was balanced in Q4 2024: 5 funds opened new positions, 5 closed out, 11 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $379K. The largest seller was UBS Group, cutting an estimated $162K.
- 30 institutional investors held MediciNova (MNOV) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $11M of MediciNova stock for Q4 2024, up 6% quarter-over-quarter.
- 5 funds opened new MediciNova positions in Q4 2024 and 5 closed out, a net change of 0 holders.
- The largest MediciNova buyer in Q4 2024 was Susquehanna International Group, an estimated $379K added.
- The largest MediciNova seller in Q4 2024 was UBS Group, an estimated $162K sold.
Based on aggregated 13F filings for Q4 2024.